Generic MICONAZOLE NITRATE; WHITE PETROLATUM; ZINC OXIDE INN entry, pharmaceutical patent expiration information and freedom to operate

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Mylan	VUSION	miconazole nitrate; white petrolatum; zinc oxide	OINTMENT;TOPICAL	021026-001	Feb 16, 2006		RX	Yes	Yes	8,147,852	⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Mylan	VUSION	miconazole nitrate; white petrolatum; zinc oxide	OINTMENT;TOPICAL	021026-001	Feb 16, 2006	4,911,932	⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Subscribe to access the full database, or Start Trial
Country	Patent Number	Title	Estimated Expiration
World Intellectual Property Organization (WIPO)	2008019030		⤷ Start Trial
>Country	>Patent Number	>Title	>Estimated Expiration

Last updated: February 17, 2026

What is the current market size and growth rate for these active ingredients and formulations?

The global pharmaceutical market for topical antifungals, primarily driven by miconazole nitrate, is estimated at approximately $2.8 billion in 2022. This segment is projected to grow at a Compound Annual Growth Rate (CAGR) of 4.5% from 2023 to 2030, influenced by increasing prevalence of fungal infections and expanding healthcare access in emerging markets.

White petrolatum and zinc oxide are classified as dermatological excipients and active ingredients in OTC products. The overall market for topical dermatological products, which include these substances, reached roughly $17 billion in 2022 with a projected CAGR of 3.5% through 2030. Miconazole nitrate accounts for approximately $350 million of this market, with steady growth driven by prescriptions and OTC formulations.

What are the factors influencing market demand?

Prevalence of Fungal Infections

An estimated 20% of the global population experiences fungal skin infections annually.
Rising incidences of athlete’s foot, candidiasis, and diaper dermatitis sustain demand for miconazole nitrate.

Aging Population and Skin Conditions

Aging populations increase demand for skin protection agents such as zinc oxide and petrolatum.
Increasing skin barrier disorders promote OTC use of zinc oxide and petrolatum for moisture retention and barrier repair.

Regulatory Environment

Expedited approvals in emerging markets facilitate faster product launches.
Changes in OTC classification can influence sales volume.

Product Innovation and Combination Formulations

Development of combination products with enhanced efficacy or reduced side effects maintains competitive edge.
Innovations that improve bioavailability or reduce formulation costs expand market share.

How does competition impact financial outlooks?

Several major pharmaceutical companies dominate the market for miconazole nitrate, with key players including Bayer, Johnson & Johnson, and Sun Pharmaceutical. These companies invest heavily in R&D and marketing to preserve market share.

In the excipient sector, niche manufacturers supply zinc oxide and petrolatum, with some facing pressure from low-cost competitors in emerging markets. Price pressures from generic suppliers can compress profit margins but also increase accessible markets.

Market entry barriers for new formulations are moderate, mainly due to regulatory compliance, but patent protections for certain formulations can restrict immediate generic competition.

What are recent trends affecting the financial outlook?

Growth of OTC sales: An increasing preference for OTC antifungal and skin protection products in developed markets sustains revenue streams.
Emergence of bioequivalent generics: Introduction of cost-effective generics in late 2020s exerted downward pricing pressure.
Shift toward topical over systemic therapies: Reduced reliance on oral antifungals favors topical formulations, benefitting miconazole nitrate sales.
Supply chain constraints: Disruptions in raw material procurement, especially for zinc oxide, have temporarily impacted manufacturing costs.

What are the revenue projections for key products?

Product	2022 Revenue (USD millions)	Estimated CAGR	2030 Projection (USD millions)
Miconazole nitrate	350	4.5%	530
White petrolatum	Included in OTC derm products	3.5%	Included in overall OTC derm product growth
Zinc oxide	Included in OTC derm products	3.5%	Included in overall OTC derm product growth

Specific product revenues associated with zinc oxide and petrolatum are embedded within broader OTC topical markets. Their consistent demand provides stable revenue streams but with limited high-growth potential absent new formulations.

What are key risks and opportunities?

Risks:

Regulatory restrictions on OTC status or new safety guidelines.
Price competition among generics.
Raw material supply disruptions impacting manufacturing costs.

Opportunities:

Expansion into emerging markets with growing dermatological needs.
Development of combination therapies enhancing efficacy.
Innovations in formulation improving stability and patient compliance.

Key Takeaways

The global topical antifungal and dermatological market is expanding, with miconazole nitrate leading growth driven by fungal infection prevalence.
Excipients like zinc oxide and petrolatum maintain stable demand, supporting consistent revenue.
Market growth is influenced by demographic trends, product innovation, and regulatory shifts.
Competition from generics and supply chain issues pose risks; however, opportunities exist via emerging markets and product development.
Revenue projections indicate moderate growth over the next decade, with miconazole nitrate experiencing the most significant increase.

FAQs

What factors most influence the growth of miconazole nitrate products? Rising fungal infection rates, expanding OTC sales, and product innovations are primary drivers.
How do regulatory changes affect market dynamics? Shifts in over-the-counter classification, safety requirements, or patent protections influence product availability and competition.
What is the role of excipients like zinc oxide and petrolatum in market growth? Their use in skin protection and barrier repair maintains steady demand in dermatological formulations.
Are there opportunities for market entrants in this space? Yes, particularly in emerging markets, through cost-effective generics and innovative combination products.
How will raw material availability impact future revenues? Disruptions in zinc oxide supply and cost increases for petrolatum could affect margins but can be mitigated by supply chain diversification.

Sources: [1] MarketsandMarkets, "Topical Antifungal Market," 2023.
[2] Grand View Research, "Dermatologicals Market Size," 2022.
[3] IQVIA, "OTC Market Trends," 2022.

International Patents:	1
US Patents:	1
Tradenames:	1
Applicants:	1
NDAs:	1
Finished Product Suppliers / Packagers:	1
DailyMed Link:	miconazole nitrate; white petrolatum; zinc oxide at DailyMed

Miconazole nitrate; white petrolatum; zinc oxide - Generic Drug Details

What are the generic drug sources for miconazole nitrate; white petrolatum; zinc oxide and what is the scope of patent protection?

Summary for miconazole nitrate; white petrolatum; zinc oxide

Pharmacology for miconazole nitrate; white petrolatum; zinc oxide

Anatomical Therapeutic Chemical (ATC) Classes for miconazole nitrate; white petrolatum; zinc oxide

US Patents and Regulatory Information for miconazole nitrate; white petrolatum; zinc oxide

Expired US Patents for miconazole nitrate; white petrolatum; zinc oxide

International Patents for miconazole nitrate; white petrolatum; zinc oxide

Market Dynamics and Financial Trajectory for Miconazole Nitrate, White Petrolatum, and Zinc Oxide